The certificate of analysis for GLP-3 Reta 30mg, lot ACE-3310727, issued by ILS Laboratories on Sep 3, 2026. Every result below is copied from the certificate as the laboratory reported it, and the document itself is further down this page.
Certificate of analysisLOT ACE-3310727
ProductGLP-3 Reta 30mg
Name on certificateRetatrutide
LotACE-3310727
LaboratoryILS Laboratories
AccreditationISO/IEC 17025
Certificate no.COA-2026-ATKEJB
Test typeFull QC Panel
Sample receivedAug 27, 2026
AnalysedSep 3, 2026
AppearanceGood
HPLC purity99.90%
IdentityRetatrutide (HPLC)
Overall resultPass
Verify with ILS Laboratories
Opens this certificate on the laboratory’s own site, access code 9RPHH9C5.
View GLP-3 Reta → Every GLP-3 Reta COA →Results as reported
| Test | Method | Result | Specification | Status |
|---|---|---|---|---|
| Purity | HPLC | 99.90% | — | Pass |
| Net Peptide Content | — | 32.2mg | — | Reported |
| Identity | HPLC | Retatrutide | — | Pass |
| Fentanyl Screen | — | Not Detected | — | Pass |
| Heavy Metals | ICP-MS | Not Detected | — | Pass |
| Sterility | PCR | No Growth | — | Pass |
| Endotoxin | USP <85> | 0.101 EU/mL | — | Reported |
“Reported” means the certificate gives a value without a pass or fail against a limit.
The certificate
More certificates
- GLP-3 Reta COA: every lot
- GLP-3 Reta 10mg, lot ACE-4798089
- GLP-3 Reta 20mg, lot ACE-2753055
- Purity index: every lot by HPLC purity
- Lot number lookup and all certificates
Sold for laboratory research use only.
